» Articles » PMID: 3714096

[Iodine and Delayed Immunity]

Overview
Journal Minerva Med
Specialty General Medicine
Date 1986 May 7
PMID 3714096
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Iodine was and is sometimes used therapeutically in various pathologies where the immune mechanism is known to play a dominant role. It has in fact been administered to patients with tubercular granulomatous, lepromatous, syphilitic and mycotic lesions where it facilitates cure. This effect does not depend on iodine's action on the micro-organism responsible. Iodine may also be used in Villanova-Panol Panniculitis, in erythema nodosum, in nodular vasculitis, erythema multiforme and Sweet's syndrome. Oral iodine is also very effective in the lymphatic-cutaneous form of sporotrichosis. In order to establish a relationship between dietary iodine and immune response, 607 infants residing in an area of endemic goitre were studied: 215 were given Lugol solution (2 drops a week for about 8 months) and 392 not. The immune response was assessed by the skin test method using tetanic toxoid and a clear correlation was shown between this and lymphocyte stimulation and monocytic chemotaxis tests. The test was considered positive when an infiltration of at least 5 mm in diameter was shown after 48 hours (in the U.S. 80% of paediatric cases aged 2-10 years old were positive). A significant difference was noted in the average diameter of the infiltrations after the tetanic toxoid skin test in the two groups considered (P less than 0.001). The results appear to indicate that an adequate iodine intake is necessary for normal retarded immune response. The molecular mechanism by which iodine increases immune response is still to be decided.

Citing Articles

A Role for Iodide and Thyroglobulin in Modulating the Function of Human Immune Cells.

Bilal M, Dambaeva S, Kwak-Kim J, Gilman-Sachs A, Beaman K Front Immunol. 2017; 8:1573.

PMID: 29187856 PMC: 5694785. DOI: 10.3389/fimmu.2017.01573.


Toxoplasmosis--a global threat. Correlation of latent toxoplasmosis with specific disease burden in a set of 88 countries.

Flegr J, Prandota J, Sovickova M, Israili Z PLoS One. 2014; 9(3):e90203.

PMID: 24662942 PMC: 3963851. DOI: 10.1371/journal.pone.0090203.